Abstract:Obesity is often associated with reduced plasma insulin-like growth factor 1 (IGF-1) levels, oxidative stress, mitochondrial damage, and cardiac dysfunction. This study was designed to evaluate the impact of IGF-1 on high-fat diet–induced oxidative, myocardial, geometric, and mitochondrial responses. FVB and cardiomyocyte-specific IGF-1 overexpression transgenic mice were fed a low- (10%) or high-fat (45%) diet to induce obesity. High-fat diet feeding led to glucose intolerance, elevated plasma levels of leptin, interleukin 6, insulin, and triglyceride, as well as reduced circulating IGF-1 levels. Echocardiography revealed reduced fractional shortening, increased end-systolic and end-diastolic diameter, increased wall thickness, and cardiac hypertrophy in high-fat–fed FVB mice. High-fat diet promoted reactive oxygen species generation, apoptosis, protein and mitochondrial damage, reduced ATP content, cardiomyocyte cross-sectional area, contractile and intracellular Ca2+ dysregulation (including depressed peak shortening and maximal velocity of shortening/relengthening), prolonged duration of relengthening, and dampened intracellular Ca2+ rise and clearance. Western blot analysis revealed disrupted phosphorylation of insulin receptor and postreceptor signaling molecules insulin receptor substrate 1 (tyrosine/serine phosphorylation), Akt, glycogen synthase kinase 3&bgr;, forkhead transcriptional factors, and mammalian target of rapamycin, as well as downregulated expression of mitochondrial proteins peroxisome proliferator-activated receptor-&ggr; coactivator 1&agr; and uncoupling protein 2. Intriguingly, IGF-1 mitigated high-fat–diet feeding-induced alterations in reactive oxygen species, protein and mitochondrial damage, ATP content, apoptosis, myocardial contraction, intracellular Ca2+ handling, and insulin signaling but not whole body glucose intolerance and cardiac hypertrophy. Exogenous IGF-1 treatment also alleviated high-fat diet–induced cardiac dysfunction. Our data revealed that IGF-1 alleviates high-fat diet–induced cardiac dysfunction despite persistent cardiac remodeling, possibly because of preserved cell survival, mitochondrial function, and insulin signaling.

High Glucose Induces Cardiac Insulin-Like Growth Factor I Resistance in Ventricular Myocytes: Role of Akt and ERK Activation

O-GlcNAcylation Involvement in High Glucose-Induced Cardiac Hypertrophy Via ERK1/2 and Cyclin D2

Inhibition of PI-3 Kinase/akt/mtor, but Not Calcineurin Signaling, Reverses Insulin-Like Growth Factor I-induced Protection Against Glucose Toxicity in Cardiomyocyte Contractile Function

Attenuated Cardiac Contractile Responsiveness to Insulin-Like Growth Factor I in Ventricular Myocytes from Biobreeding Spontaneous Diabetic Rats

The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats

The signal transduction pathway of PKC/NF-kappa B/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats.

[Influence of Various Glucose Levels on the Structure and Function of Cultured Neonatal Rats Cardiomyocytes].

IGF-I Attenuates Diabetes-Induced Cardiac Contractile Dysfunction in Ventricular Myocytes

Prediabetic Insulin Resistance Is Not Permissive To The Development Of Cardiac Resistance To Insulin-Like Growth Factor I In Ventricular Myocytes

Impaired Cardiac Function and IGF-I Response in Myocytes from Calmodulin-Diabetic Mice: Role of Akt and RhoA.

Abstract 11165: Activation of IGF-1/PI3/GSK-3ss Signaling Prevents High Glucose-induced Transition of Human Cardiac Progenitor Cells into Fibroblasts

Activation Of Pi3k Gamma/Akt Pathway Increases Cardiomyocyte Hmgb1 Expression In Diabetic Environment

Alpha 2-Heremans Schmid Glycoprotein, A Putative Inhibitor Of Tyrosine Kinase, Prevents Glucose Toxicity Associated With Cardiomyocyte Dysfunction

High Levels of Glucose Induce Apoptosis in Cardiomyocyte Via Epigenetic Regulation of the Insulin-Like Growth Factor Receptor

IGF-I Alleviates Diabetes-Induced RhoA Activation, Enos Uncoupling, and Myocardial Dysfunction.

Activation of PI3Kγ/Akt Pathway Increases Cardiomyocyte HMGB1 Expression in Diabetic Environment

Insulin-Like Growth Factor 1 Alleviates High-Fat Diet-Induced Myocardial Contractile Dysfunction: Role of Insulin Signaling and Mitochondrial Function.

Transgenic Overexpression of Insulin-Like Growth Factor I Prevents Streptozotocin-Induced Cardiac Contractile Dysfunction and Beta-Adrenergic Response in Ventricular Myocytes

PPARγ–PI3K/AKT–NO Signal Pathway is Involved in Cardiomyocyte Hypertrophy Induced by High Glucose and Insulin

AT 1 Blockade Prevents Glucose-Induced Cardiac Dysfunction in Ventricular Myocytes

STAT1/3 and ERK1/2 Synergistically Regulate Cardiac Fibrosis Induced by High Glucose.